Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. (Q51977322)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 February 2007

Language	Label	Description	Also known as
English	Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.	scientific article published on 14 February 2007

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

1 reference

based on heuristic

inferred from title

David C. Montefiori

8

object named as

David C Montefiori

1 reference

Europe PubMed Central

19 April 2018

David B. Weiner

14

object named as

David B Weiner

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

author name string

Siew-Yen Chong

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Michael A Egan

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Michele A Kutzler

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Shakuntala Megati

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Amjed Masood

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Vidia Roopchard

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Dorys Garcia-Hand

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Jorge Quiroz

9

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Margherita Rosati

10

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Eva B Schadeck

11

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Jean D Boyer

12

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

George N Pavlakis

13

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Maninder Sidhu

15

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

John H Eldridge

16

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Zimra R Israel

17

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

language of work or name

0 references

publication date

14 February 2007

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

25

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

26

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

4967-4982

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Interleukin-15 protects from lethal apoptosis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Memory phenotype CD8(+) T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

IL-15 enhances survival and function of HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Increased CD8+ T cell memory to concurrent infection at the expense of increased erosion of pre-existing memory: the paradoxical role of IL-15.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

AIDS vaccine models: challenging challenge viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.070

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.11.070

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17335943

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51977322&oldid=2150908021"